Australia: Stroke rates decline, but many still preventable
The rate of strokes suffered by Australians has dropped over the past 20 years, while strokes caused by an irregular heartbeat now account for one third of all strokes, according to new research led by the University of Adelaide.
Cardiology
May 16, 2013 |
not rated yet |
0
Study finds plasmin—delivered through a bubble—more effective than tPA in busting clots
A new study from the University of Cincinnati has found that, when delivered via ultrasound, the natural enzyme plasmin is more effective at dissolving stroke-causing clots than the standard of care, recombinant tissue plasminogen ...
Cardiology
May 15, 2013 |
not rated yet |
0
|
One in three stroke emergencies don't use EMS
More than a third of stroke patients don't get to the hospital by ambulance, even though that's the fastest way to get there, according to new research in Circulation: Cardiovascular Quality and Outcomes, an American Heart ...
Cardiology
Apr 30, 2013 |
not rated yet |
0
ESC guide on new oral anticoagulant drugs
A practical guide on the use of the new oral anticoagulants (NOACs) has been produced by the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC). A guide was needed to summarise existing information ...
Cardiology
Apr 26, 2013 |
not rated yet |
0
Tart cherries linked to reduced risk of stroke
(Medical Xpress)—For the millions of Americans at risk for heart disease or diabetes, a diet that includes tart cherries might actually be better than what the doctor ordered, according to new animal research ...
Health
Apr 24, 2013 |
3.8 / 5 (4) |
0
|
Certified stroke centers more likely to give clot-busting drugs
Stroke patients are three times more likely to receive clot-busting medication if treated at a certified stroke center, according to a study in the Journal of the American Heart Association.
Cardiology
Mar 26, 2013 |
not rated yet |
0
US probes Sanofi over blockbuster drug Plavix (Update 2)
The U.S. Justice Department is investigating drug maker Sanofi's disclosures to the Food and Drug Administration about different responses to its blockbuster blood thinner Plavix.
Medications
Mar 11, 2013 |
not rated yet |
0
Stroke risk in elderly treated with antipsychotics is newly linked to specific drug actions
Antipsychotic administration in the elderly is associated with an increased risk for cerebrovascular accident, more commonly known as stroke; a new study published in Biological Psychiatry provides additional insight into t ...
Psychology & Psychiatry
Mar 11, 2013 |
not rated yet |
0
Niacin therapy unhelpful, occasionally harmful, study says
A combination drug containing niacin failed to lower the risk of heart attacks or strokes and even proved harmful for some with vascular disease, a study released Saturday reported.
Cardiology
Mar 09, 2013 |
4 / 5 (1) |
0
New FDA-approved clot removal devices show promise for treating stroke patients
Specialists at Stony Brook Medicine's Cerebrovascular and Stroke Center (CVC) are treating patients with a new generation of blood clot removal devices that show promise in successfully revascularizing stroke ...
Cardiology
Feb 26, 2013 |
not rated yet |
0
FDA seizes illegal dietary supplements in Florida
(AP)—The Food and Drug Administration says U.S. marshals have seized illegal dietary supplements from a Florida company because some may contain a dangerous pharmaceutical ingredient.
Medications
Feb 14, 2013 |
not rated yet |
0
Study of brain cooling and clot-busting drug therapy for stroke receives FDA OK to expand
An international multicenter clinical trial led by a Cedars-Sinai neurologist on the combination of brain cooling and "clot-busting" drug therapy after stroke has received Food and Drug Administration approval to expand from ...
Neuroscience
Feb 06, 2013 |
not rated yet |
0
Merck warns doctors to stop prescribing Tredaptive
Drugmaker Merck says it is suspending its sale of the cholesterol drug Tredaptive and is telling doctors to quit prescribing the medicine.
Medications
Jan 11, 2013 |
1 / 5 (1) |
0
FDA clears anticlotting drug Eliquis
The Food and Drug Administration says it has approved the anticlotting drug Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc. It's a potential blockbuster drug in a new category of medicines to prevent strokes ...
Medications
Dec 28, 2012 |
not rated yet |
0
Bristol-Myers, Pfizer's Eliquis approved in Japan
Regulators in Japan have approved sales of an anticlotting drug called Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc., that's a potential blockbuster in a new category of medicines to prevent strokes and heart ...
Medications
Dec 26, 2012 |
not rated yet |
0
